1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Molecular Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Molecular Diagnostics Market, by Product
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast
8.1.2. Reagents
8.1.2.1. Market Revenue and Forecast
8.1.3. Services & Software
8.1.3.1. Market Revenue and Forecast
9.1. U.S. Molecular Diagnostics Market, by Test Location
9.1.1. Central laboratories
9.1.1.1. Market Revenue and Forecast
9.1.2. Point of care
9.1.2.1. Market Revenue and Forecast
9.1.3. Over the counter or self-test kits
9.1.3.1. Market Revenue and Forecast
10.1. U.S. Molecular Diagnostics Market, by Technology
10.1.1. Polymerase Chain Reaction (PCR)
10.1.1.1. Market Revenue and Forecast
10.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
10.1.2.1. Market Revenue and Forecast
10.1.3. DNA Sequencing & Next- generation Sequencing (NGS)
10.1.3.1. Market Revenue and Forecast
10.1.4. In Situ Hybridization (ISH)
10.1.4.1. Market Revenue and Forecast
10.1.5. DNA Microarrays
10.1.5.1. Market Revenue and Forecast
10.1.6. Others
10.1.6.1. Market Revenue and Forecast
11.1. U.S. Molecular Diagnostics Market, by Application
11.1.1. Infectious diseases
11.1.1.1. Market Revenue and Forecast
11.1.2. Oncology
11.1.2.1. Market Revenue and Forecast
11.1.3. Genetic testing
11.1.3.1. Market Revenue and Forecast
11.1.4. Neurological disease
11.1.4.1. Market Revenue and Forecast
11.1.5. Microbiology
11.1.5.1. Market Revenue and Forecast
12.1. U.S. Molecular Diagnostics Market, by End User
12.1.1. Diagnostic Laboratories
12.1.1.1. Market Revenue and Forecast
12.1.2. Hospitals & Clinics
12.1.2.1. Market Revenue and Forecast
12.1.3. Others
12.1.3.1. Market Revenue and Forecast
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product
13.1.6.2. Market Revenue and Forecast, by Test Location
13.1.6.3. Market Revenue and Forecast, by Technology
13.1.6.4. Market Revenue and Forecast, by Application
13.1.6.5. Market Revenue and Forecast, by End User
14.1. Siemens Healthineers AG (Germany)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Quidel Corporation (US)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. F. Hoffmann-La Roche Ltd. (Switzerland)
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Hologic, Inc. (US)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Thermo Fisher Scientific, Inc. (US)
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Danaher Corporation (US)
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Illumina, Inc. (US)
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Becton, Dickinson and Company (US)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Grifols, S.A. (Spain)
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. PerkinElmer, Inc. (US)
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
